Posaconazole Echino...

Posaconazole Echinocandin B0
Posaconazole Echinocandin B0
Posaconazole Echinocandin B0

Posaconazole Echinocandin B0

Min.Order / FOB Price:Get Latest Price

100 Kilogram

Negotiable

  • Min.Order :100 Kilogram
  • Purity: 99%
  • Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other

Keywords

RARECHEM AH PB 0251 171228-49-2 C37H42F2N8O4

Quick Details

  • Appearance:powder
  • Application:171228-49-2
  • PackAge:Depended
  • ProductionCapacity:300|Kilogram|Month
  • Storage:Refrigerator
  • Transportation:by air or by sea

Superiority:

Posaconazole Basic information
Pharmacological effects Pharmacokinetics Clinical indications and usage
Product Name: Posaconazole
Synonyms: Posaconazole;2,5-Anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol;Noxafil;Sch 56592;4-[4-[4-[4-[[(3R,5R)-5-(2,4-Difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one;HYDROXYPROPYL]-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE;Posaconazole for research;1-((1S,2S)-1-Ethyl-2-hydroxypropyl)-4-{4-[4-(4-{[(5S,3R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazolylmethyl)oxolan-3-yl]methoxy}phenyl)piperazinyl]phenyl}-1,2,4-triazolin-5-one
CAS: 171228-49-2
MF: C37H42F2N8O4
MW: 700.78
EINECS: 200-659-6
Product Categories: Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;API;Noxafil;Inhibitors
Mol File: 171228-49-2.mol
Posaconazole Structure
 
Posaconazole Chemical Properties
mp  170-1720C
storage temp.  -20°C Freezer
CAS DataBase Reference 171228-49-2(CAS DataBase Reference)
 
Safety Information
Hazard Codes  F,T
Risk Statements  11-23/24/25-39/23/24/25
Safety Statements  7-16-36/37-45
Hazardous Substances Data 171228-49-2(Hazardous Substances Data)
MSDS Information
 
 
Posaconazole Usage And Synthesis
Pharmacological effects Posaconazole (posaconazole) is derived from itraconazole. It is currently subject to III phase clinical trials. Its pharmacological effects are similar with azoles, but compared with itraconazole, it has a stronger inhibitory effect on the C14 demethylation of steroid, especially for Aspergillus.
Pharmacokinetics Studies on dosage and dosage protocol have shown that the rate of absorption and elimination rate is in line with the single-compartment model. There are significant differences on the relative bioavailability of different doses of oral suspension. It can be taken separately (every 12 hours or every 6 hours) which can significantly improve the bioavailability with the protein binding rate of 98% to 99%. With respect to tablets, the bioavailability of suspensions increase and food can significantly improve the speed and extent of absorption of drug absorption. An investigation of renal dysfunction on the pharmacokinetics of the drug study results has showed that the drug can’t be removed by hemodialysis without being affected by hemodialysis. Single-dose study has showed that patients with varying degrees of chronic kidney disease have no necessity for dosage adjustment. The Half-life of this is about 25 hours which can be primarily metabolized by the liver.
Clinical indications and usage It can be clinically used for the treatment of aspergillosis, zygnmycosis, and fusariumsis and can also be used for infection caused by part of fluconazole-resistant Candida genus. Studies have shown that posaconazole can widely and effectively applied to the treatment of phaeohyphomycosis and improve the infection survival rate of dermatitidis infection in a dose-dependent manner. The drug, as second-line drugs, has an effective rate of 44% to 78% against the invasive aspergillosis which is resistant to amphotericin B and itraconazole. It also has an effective rate of 71% against the zygomycete fungi. The drug is an oral suspension with the recommended dose of 200mg and 4 times per day with meals and taken orally for 7 to 10 days. This dose can also be maintained or changed to 400mg with oral administration of 2 times per day. The steady-state plasma concentration can reach within 7 to 10 days.
The above information is edited by the Chemicalbook of Dai Xiongfeng.
Chemical Properties White Solid
Usage Orally active triazole antifungal.
Usage Posaconazole is a sterol C14ɑ demethylase inhibitor with an IC50 of 0.25 nM
 
 
 

 

 

 

 

 

Service we provide:

 

1. Mixed container, we can mix different items in one container.

2. Quality control, before shipment, free sample for test. after shipment,  keep sample for 3 years

3. Prompt shipment with professional documents

4. Packing as your request, with photo before shipment

 

 

 

 

 

 

 

 

 

Details:

  • Exhibition in shanghai

 

 

We have clients throughout the world:

Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet your desire.

 

 

 

 

 

 

 

Our Laboratoy

 

 

We have our own independent lab test center:

This makes sure that our technology support is reliable and authoritative.All of self-owned fine chemicals are manufactured strictly in accordance with international standard.,and also has scientific cooperation with local colleges and institutes.

 

 

 

 

 

Our factory

 

 

High quality with competitive price:

We are manufacturer and can provide high quality products with factory price

 

 

 

 

 

 

Package  & Shipment

 

 

Fast and safe delivery:

Parcels can be sent out within 24 hours after payment. Tracking number is available

Secure and discreet shipment. You have various choices of transportation methods

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View